Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-14
REV
Q1 2021Est.ActualSurprise
EPS-83.360
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
HOWLWerewolf Therapeutics-2.23%

Werewolf Therapeutics Frequently Asked Questions

Q

How do I buy Werewolf Therapeutics (HOWL) stock?

A

You can purchase shares of Werewolf Therapeutics (NASDAQ: HOWL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Werewolf Therapeutics's (HOWL) competitors?

A

There are no as such competitors for Werewolf Therapeutics.

Q

What is the target price for Werewolf Therapeutics (HOWL) stock?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by Evercore ISI Group on May 25, 2021. The analyst firm set a price target for 23.00 expecting HOWL to rise to within 12 months (a possible 87.45% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Werewolf Therapeutics (HOWL)?

A

The stock price for Werewolf Therapeutics (NASDAQ: HOWL) is $12.27 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Werewolf Therapeutics (HOWL) pay a dividend?

A

There are no upcoming dividends for Werewolf Therapeutics.

Q

When is Werewolf Therapeutics (NASDAQ:HOWL) reporting earnings?

A
Werewolf Therapeutics’s Q2 earnings are confirmed for after-market on August 14, 2021.
Q

Is Werewolf Therapeutics (HOWL) going to split?

A

There is no upcoming split for Werewolf Therapeutics.

Q

What sector and industry does Werewolf Therapeutics (HOWL) operate in?

A

Werewolf Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.